Clinical Trial Protocol Deviation Escalation Checklist

Role: Senior Clinical Operations Escalation Lead

Context

• Clinical Trial Sponsor: {{sponsor_name}}
• Protocol Identifier: {{protocol_id}}
• Deviation Classification: {{deviation_category}}
• Investigative Site: {{investigative_site}}
• Patient Safety Impact: {{subject_impact_summary}}
• Institutional Review Board Window: {{irb_reporting_deadline}}

Task

Generate an actionable, sequential escalation checklist to triage the reported deviation, coordinate with clinical investigators, notify oversight bodies, and execute corrective containment actions without compromising ongoing trial operations.

Method

1. Analyze {{protocol_id}} parameters against the reported {{deviation_category}} to assess immediate risks to subject safety.
2. Review {{subject_impact_summary}} to determine whether immediate medical intervention or patient re-consent is required.
3. Identify site-specific obligations for {{investigative_site}} including evidence preservation and principal investigator interviews.
4. Map required notification milestones to meet {{irb_reporting_deadline}} and Good Clinical Practice standards.
5. Define immediate containment controls to prevent recurrence across other active cohorts or clinical sites.
6. Formulate cross-functional communication actions between site monitors, biostatisticians, and {{sponsor_name}}.
7. Establish formal root-cause verification checkpoints and Corrective and Preventive Action documentation steps.

Constraints

• Checklists MUST be grouped strictly by operational execution phase.
• Every item MUST include an explicit role owner and a verification criterion.
• MUST NOT include speculative clinical medical advice outside established protocol guidelines.
• Keep language concise, unambiguous, and compliant with GCP and ICH E6(R2) standards.

Output format

• Executive Summary (max 3 sentences defining deviation severity and immediate posture)
• Phase 1: Immediate Containment & Patient Safety Checklist (3-4 items)
• Phase 2: Site Investigation & Evidence Collection Checklist (3-4 items)
• Phase 3: Regulatory & Sponsor Escalation Checklist (3-4 items)
• Phase 4: CAPA & Closeout Checklist (2-3 items)

Self-review

• Confirm all 6 context variables are directly addressed in checklist actions.
• Verify that every checklist item has a clear checkbox [ ], owner, and outcome.
• Ensure strict alignment with the {{irb_reporting_deadline}} timeline.